Search research articles
Contact Us
Filters
Showing results (1-10 of 65) with videos related to
Page
of 7
Sort By:
Current HIV Research
|
April 1, 2004
B lymphocyte dysfunctions in HIV infection
Angelo De Milito
Future Oncology (London, England)
|
March 25, 2006
Tumor acidity, chemoresistance and proton pump inhibitors
Angelo De Milito, Stefano Fais
Expert Opinion on Pharmacotherapy
|
June 17, 2005
Proton pump inhibitors may reduce tumour resistance
Angelo De Milito, Stefano Fais
Current Medicinal Chemistry
|
December 30, 2016
Pathobiology and Therapeutic Implications of Tumor Acidosis
Jenny Viklund, Sofia Avnet, Angelo De Milito
Current Pharmaceutical Design
|
February 25, 2012
A rationale for the use of proton pump inhibitors as antineoplastic agents
Angelo De Milito, Maria Lucia Marino, Stefano Fais
Cancer Research
|
November 17, 2007
Targeting vacuolar H+-ATPases as a new strategy against cancer
Stefano Fais, Angelo De Milito, Haiyan You, et al.
Vaccine
|
January 1, 2008
B cell immunopathology during HIV-1 infection: lessons to learn for HIV-1 vaccine design
Alberto Cagigi, Anna Nilsson, Angelo De Milito, et al.
Brain Pathology (Zurich, Switzerland)
|
February 13, 2003
Astrocyte activation and apoptosis: their roles in the neuropathology of HIV infection
Farideh Sabri, Kehmia Titanji, Angelo De Milito, et al.
Seminars in Cancer Biology
|
February 12, 2017
Therapeutic implications of tumor interstitial acidification
Iryna Kolosenko, Sofia Avnet, Nicola Baldini, et al.
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society
|
February 23, 2018
Spheroid-based 3D cell cultures identify salinomycin as a promising drug for the treatment of chondrosarcoma
Francesca Perut, Francesca V Sbrana, Sofia Avnet, et al.
Page
of 7
Search research articles
Search
Showing results (1-10 of 65) with videos related to
Sort By:
Page
of 7
Current HIV Research
|
April 1, 2004
B lymphocyte dysfunctions in HIV infection
Angelo De Milito
Future Oncology (London, England)
|
March 25, 2006
Tumor acidity, chemoresistance and proton pump inhibitors
Angelo De Milito, Stefano Fais
Expert Opinion on Pharmacotherapy
|
June 17, 2005
Proton pump inhibitors may reduce tumour resistance
Angelo De Milito, Stefano Fais
Current Medicinal Chemistry
|
December 30, 2016
Pathobiology and Therapeutic Implications of Tumor Acidosis
Jenny Viklund, Sofia Avnet, Angelo De Milito
Current Pharmaceutical Design
|
February 25, 2012
A rationale for the use of proton pump inhibitors as antineoplastic agents
Angelo De Milito, Maria Lucia Marino, Stefano Fais
Cancer Research
|
November 17, 2007
Targeting vacuolar H+-ATPases as a new strategy against cancer
Stefano Fais, Angelo De Milito, Haiyan You, et al.
Vaccine
|
January 1, 2008
B cell immunopathology during HIV-1 infection: lessons to learn for HIV-1 vaccine design
Alberto Cagigi, Anna Nilsson, Angelo De Milito, et al.
Brain Pathology (Zurich, Switzerland)
|
February 13, 2003
Astrocyte activation and apoptosis: their roles in the neuropathology of HIV infection
Farideh Sabri, Kehmia Titanji, Angelo De Milito, et al.
Seminars in Cancer Biology
|
February 12, 2017
Therapeutic implications of tumor interstitial acidification
Iryna Kolosenko, Sofia Avnet, Nicola Baldini, et al.
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society
|
February 23, 2018
Spheroid-based 3D cell cultures identify salinomycin as a promising drug for the treatment of chondrosarcoma
Francesca Perut, Francesca V Sbrana, Sofia Avnet, et al.
Page
of 7